(2S,5S,8S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S)-50-amino-2,5,14,17,35,38-hexakis(4-aminobutyl)-8,41-dibenzyl-20-sec-butyl-26-(3-guanidinopropyl)-32,44-diisobutyl-23,29-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49-hexadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-hexadecaazahenpentacontan-1-oic acid

ID: ALA5279749

Chembl Id: CHEMBL5279749

Max Phase: Preclinical

Molecular Formula: C91H158N26O18

Molecular Weight: 1904.43

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O

Standard InChI:  InChI=1S/C91H158N26O18/c1-10-56(6)75(89(133)113-66(38-21-27-45-96)82(126)109-62(34-17-23-41-92)79(123)103-53-74(119)107-71(50-60-30-13-11-14-31-60)87(131)111-64(36-19-25-43-94)83(127)114-68(90(134)135)39-22-28-46-97)117-78(122)59(9)104-80(124)67(40-29-47-101-91(99)100)108-77(121)58(8)105-85(129)70(49-55(4)5)115-84(128)65(37-20-26-44-95)110-81(125)63(35-18-24-42-93)112-88(132)72(51-61-32-15-12-16-33-61)116-86(130)69(48-54(2)3)106-73(118)52-102-76(120)57(7)98/h11-16,30-33,54-59,62-72,75H,10,17-29,34-53,92-98H2,1-9H3,(H,102,120)(H,103,123)(H,104,124)(H,105,129)(H,106,118)(H,107,119)(H,108,121)(H,109,126)(H,110,125)(H,111,131)(H,112,132)(H,113,133)(H,114,127)(H,115,128)(H,116,130)(H,117,122)(H,134,135)(H4,99,100,101)/t56-,57-,58-,59-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,75-/m0/s1

Standard InChI Key:  ONLSJDIKJYMIKM-NMRBWUJKSA-N

Alternative Forms

1. Parent:

   

   ALA5279749

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1904.43

Molecular Weight (Monoisotopic): 1903.2247

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Zhang M, Ouyang J, Fu L, Xu C, Ge Y, Sun S, Li X, Lai S, Ke H, Yuan B, Yang K, Yu H, Gao L, Wang Y..  (2022)  Hydrophobicity Determines the Bacterial Killing Rate of α-Helical Antimicrobial Peptides and Influences the Bacterial Resistance Development.,  65  (21.0): [PMID:36283984] [10.1021/acs.jmedchem.2c01238]

Source

Source(1):

• Scientific Literature